Phase II study of PRO95780 plus rituximab in patients with relapsed follicular non-Hodgkin's lymphoma (NHL). Background: Solitary plasmacytoma is a rare plasma-cell neoplasm. We wanted to assess the ...
Extramedullary plasmacytoma and solitary plasmacytoma represent rare manifestations of plasma cell dyscrasias, where abnormal plasma cells accumulate as a single localised lesion. In the case of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results